CIBC Downgrades Syneron Medical

Analyst John Calcagnini says the FDA has requested that the cosmetic medical device maker resubmit its VelaSmooth application

CIBC World Downgrades Syneron Medical (ELOS ) from sector outperform to underperform.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.